Representative before the EPO

Company dna neurosearch a slash s
no operation time available
1 office
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications Inger Margrethe Schelde Madsen has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 24, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11730549

NEW POLYMORPHIC FORM OF A CALCIMIMETIC COMPOUND

IPC classification:
A61K 31/196, A61P 3/14, A61P 5/18, C07C 213/10, C07C 217/74
Applicant:
Leo Pharma A/S
Agent:
Inspicos AS (Inspicos P/S)
Agent:
Inger Margrethe Schelde Madsen, Leo Pharma A/S
Status:
EXAMINATION IN PROGRESS
EP11730884

NEW POLYMORPHIC FORM OF A CALCIMIMETIC COMPOUND

IPC classification:
A61K 31/196, A61P 3/14, A61P 5/18, C07C 213/10, C07C 217/74
Applicant:
Leo Pharma A/S
Agent:
Inspicos AS (Inspicos P/S)
Agent:
Inger Margrethe Schelde Madsen, Leo Pharma A/S
Status:
EXAMINATION IN PROGRESS
EP12806051

[1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPODIESTERASE INHIBITORS

IPC classification:
A61K 31/437, A61P 17/00, A61P 17/02, A61P 17/04, A61P 17/06, A61P 17/08, A61P 17/10, A61P 17/14, A61P 17/16, A61P 35/00, C07D 471/04
Applicant:
Leo Pharma A/S
Agent:
Inger Margrethe Schelde Madsen, Leo Pharma A/S
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16020112

BENZODIOXOLE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS

IPC classification:
A61K 31/443, A61K 31/4433, A61K 31/4436, A61P 9/00, A61P 11/00, A61P 17/00, A61P 25/00, A61P 35/00, A61P 37/00, C07D 493/10, C07D 495/10
Agent:
Inger Margrethe Schelde Madsen, Leo Pharma A/S
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature